Nephrology Dialysis Transplantation

Papers
(The H4-Index of Nephrology Dialysis Transplantation is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Erratum to: FC041 tubular epithelial cell polyploidy is essential to survive AKI but contributes to CKD progression159
Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients108
Functional adaptation after kidney tissue removal in patients is associated with increased plasma atrial natriuretic peptide concentration95
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis83
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients72
Immunoengineering for autoimmune-kidney disease70
Anti-C1Q monitoring predicts relapses of lupus nephritis62
Peer-reviewing and medical publication60
Chosing the best renal care for our patients: the evolving landscape of dialysis therapy60
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases57
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines57
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease56
Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire54
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity54
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease49
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease48
Transition of care of adolescent kidney transplant recipients—a call to action48
Are patients with primary glomerular disease at increased risk of malignancy?47
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions in adults: a randomized controlled trial47
CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future46
Work status and work ability of patients receiving kidney replacement therapy: results from a European survey44
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy44
FHL2 in arterial medial calcification in chronic kidney disease44
Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study41
Pediatric kidney care experience after the 2023 Türkiye earthquake41
Hippocampal subfield morphology in regular hemodialysis patients40
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis39
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport38
Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies38
Uromodulin biology37
Cognitive deficits associate with cerebral hypoxia during hemodialysis37
MO142: Urinary Hemopexin  As a Marker of Lupus Activity Among Egyptian SLE Patients with Proliferative Lupus Nephritis36
#3296 ADVERSE MUSCLE COMPOSITION ASSESSED BY MRI ASSOCIATES TO POOR FUNCTIONAL PERFORMANCE AND METABOLIC COMORBIDITIES IN CKD36
MO1005: Analysis of Expression of Immune System Genes that are Responsible for Activation and Inhibition of T-Cell Immune Response in Renal Transplant Recipients after Extracorporeal Photochemotherapy36
#1048 Why are felids at such a high risk of chronic kidney disease?35
0.071084976196289